Role of Pericytes in Vascular Biology

Author(s):  
Annika Armulik ◽  
Christer Betsholtz
Keyword(s):  
2015 ◽  
Vol 116 (8) ◽  
pp. 1448-1461 ◽  
Author(s):  
Jay D. Humphrey ◽  
Martin A. Schwartz ◽  
George Tellides ◽  
Dianna M. Milewicz
Keyword(s):  

2015 ◽  
Vol 116 (3) ◽  
pp. 480-488 ◽  
Author(s):  
Samuel C. Nussenzweig ◽  
Subodh Verma ◽  
Toren Finkel
Keyword(s):  

2014 ◽  
Vol 62 (2) ◽  
pp. 72-81 ◽  
Author(s):  
Maria Adele Alberelli ◽  
Erica De Candia

1996 ◽  
Vol 24 (3) ◽  
pp. 107-115 ◽  
Author(s):  
Noriyuki SAKATAI ◽  
Jing MENG ◽  
Koji MLYAMOTO ◽  
Shigeo TAKEBAYASHI ◽  
Tatsuo FURUKAWA ◽  
...  

2019 ◽  
Vol 20 (12) ◽  
pp. 3076 ◽  
Author(s):  
Candice Chapouly ◽  
Sarah Guimbal ◽  
Pierre-Louis Hollier ◽  
Marie-Ange Renault

The role of Hedgehog (Hh) signaling in vascular biology has first been highlighted in embryos by Pepicelli et al. in 1998 and Rowitch et al. in 1999. Since then, the proangiogenic role of the Hh ligands has been confirmed in adults, especially under pathologic conditions. More recently, the Hh signaling has been proposed to improve vascular integrity especially at the blood–brain barrier (BBB). However, molecular and cellular mechanisms underlying the role of the Hh signaling in vascular biology remain poorly understood and conflicting results have been reported. As a matter of fact, in several settings, it is currently not clear whether Hh ligands promote vessel integrity and quiescence or destabilize vessels to promote angiogenesis. The present review relates the current knowledge regarding the role of the Hh signaling in vasculature development, maturation and maintenance, discusses the underlying proposed mechanisms and highlights controversial data which may serve as a guideline for future research. Most importantly, fully understanding such mechanisms is critical for the development of safe and efficient therapies to target the Hh signaling in both cancer and cardiovascular/cerebrovascular diseases.


Neurology ◽  
2001 ◽  
Vol 57 (Supplement 2) ◽  
pp. S1-S4 ◽  
Author(s):  
D. J. Fitzgerald
Keyword(s):  

Stroke ◽  
2021 ◽  
Author(s):  
Nabil J. Alkayed ◽  
Marilyn J. Cipolla

The article summarizes recent studies investigating mechanisms of collateral flow variability in stroke and the role of pericytes in cerebral microcirculation and stroke.


Blood ◽  
2012 ◽  
Vol 119 (11) ◽  
pp. 2452-2457 ◽  
Author(s):  
Marie-Christine Bouton ◽  
Yacine Boulaftali ◽  
Benjamin Richard ◽  
Véronique Arocas ◽  
Jean-Baptiste Michel ◽  
...  

Abstract Serine protease inhibitors, termed serpins, are key regulators in many biologic events. Protease nexin-1 (PN-1) is a serpin that is barely detectable in plasma but found in many organs and produced by most cell types, including monocytes, platelets, and vascular cells. It has a large inhibition spectrum because it is the most efficient tissue inhibitor of thrombin but also a powerful inhibitor of plasminogen activators and plasmin. It has a high affinity for glycosaminoglycans, such as heparan sulfates, which potentiate its activity toward thrombin and target it to the pericellular space. PN-1 has been previously largely described as a crucial regulator of the proteolytic activity in nerves and of central and peripheral nervous system function. In contrast, little was known about its involvement in hemostasis and vascular biology. This article reviews recent data underlining its emerging role as a key factor in the responses of vessels to injury. Indeed, studies of PN-1–deficient mice have established important antithrombotic and antifibrinolytic properties of this serpin that have heretofore gone unrecognized. The roles of PN-1 in the areas of hemostasis and thrombosis summarized here provide insights that may allow the development of drugs and treatment strategies to prevent or limit thrombotic disorders.


Sign in / Sign up

Export Citation Format

Share Document